By Regulatory Approvals — Matthew Kurian: FDA Clears AI Tool to Predict Breast Cancer Recurrence Risk Before Surgery Oncodaily
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 18, 2026.